✦ LIBER ✦

CLOCKmay Predict the Response to Fluvoxamine Treatment in Japanese Major Depressive Disorder Patients

✍ Scribed by Taro Kishi; Tsuyoshi Kitajima; Masashi Ikeda; Yoshio Yamanouchi; Yoko Kinoshita; Kunihiro Kawashima; Tomo Okochi; Takenori Okumura; Tomoko Tsunoka; Norio Ozaki; Nakao Iwata

Book ID: 107568606
Publisher: Humana Press Inc
Year: 2009
Tongue: English
Weight: 195 KB
Volume: 11
Category: Article
ISSN: 1535-1084
DOI: 10.1007/s12017-009-8060-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Monoamine oxidase: A gene polymorphism,

Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder

✍ Keizo Yoshida; Shingo Naito; Hitoshi Takahashi; Kazuhiro Sato; Kenichi Ito; Mits 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Th2 cytokine response in Major Depressiv

Th2 cytokine response in Major Depressive Disorder patients before treatment

✍ Lenin Pavón; Gabriel Sandoval-López; María Eugenia Hernández; Frida Loría; Iris 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Gender differences in the clinical effec

Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patients

✍ SHINGO NAITO; KAZUHIRO SATO; KEIZO YOSHIDA; HISASHI HIGUCHI; HITOSHI TAKAHASHI; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

Brain activation predicts treatment impr

Brain activation predicts treatment improvement in patients with major depressive disorder

✍ Andrea C. Samson; Eva Meisenzahl; Johanna Scheuerecker; Emma Rose; Veronika Scho 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 466 KB

Predicting 6-week treatment response to

Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder

✍ Ramin Saghafi; Charlotte Brown; Meryl A. Butters; Jill Cyranowski; Mary Amanda D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 1 views

## Abstract ## Objective Approximately half of older patients treated for major depressive disorder (MDD) do not achieve symptomatic remission and functional recovery with first‐line pharmacotherapy. This study aims to characterize sociodemographic, clinical, and neuropsychologic correlates of ful

Prediction of response to paroxetine tre

Prediction of response to paroxetine treatment in patients with a depressive disorder

✍ K.A. Wittkampf⁎; H.G. Ruhe; H.C. van Weert; J. Huyser; P.E. Bindels; A.H. Schene 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB